[{"AccountsPayableCurrent_0_Q2_USD":9363225.0,"OtherAccruedLiabilitiesCurrent_0_Q2_USD":1212420.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_2_Q2_USD":14.23,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_0_Q2_USD":259886170.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_2_Q2_shares":630135.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_2_Q2_shares":28361.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_0_Q2_USD":9.07,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_0_Q2_shares":2177471.0,"ProceedsFromWarrantExercises_2_Q2_USD":3.0,"OtherAssetsNoncurrent_0_Q2_USD":139875.0,"DebtInstrumentUnamortizedDiscountNoncurrent_0_Q2_USD":231404.0,"LongTermDebtNoncurrent_0_Q2_USD":13744321.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_2_Q2_USD":10.17,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_0_Q2_USD":17.06,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0_Q2_shares":3979607.0,"ClassOfWarrantOrRightOutstanding_0_Q2_shares":37042.0,"ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_0_Q2_USD":7.03,"AmortizationOfDebtDiscountPremium_2_Q2_USD":356664.0,"EffectiveIncomeTaxRateContinuingOperations_2_Q2_pure":0.0,"Cash_0_Q2_USD":190682109.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q2_USD":190409.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_2_Q2_USD":53.75,"StockIssuedDuringPeriodSharesStockOptionsExercised_2_Q2_shares":80614.0,"CashEquivalentsAtCarryingValue_0_Q2_USD":190682109.0,"LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_0_Q2_USD":1333333.0,"InvestmentIncomeNet_2_Q2_USD":-540847.0,"InvestmentIncomeNet_1_Q2_USD":-548158.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_Q2_USD":-29284058.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q2_USD":4148025.0,"DebtInstrumentUnamortizedDiscountCurrent_0_Q2_USD":119406.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_0_Q2_USD":159414994.0,"AmortizationOfFinancingCosts_1_Q2_USD":119014.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_0_Q2_USD":17.08,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_0_Q2_shares":3973438.0,"LongTermDebtCurrent_0_Q2_USD":6547261.0,"InterestExpenseDebtExcludingAmortization_2_Q2_USD":758334.0,"EmployeeRelatedLiabilitiesCurrent_0_Q2_USD":1446891.0,"AllocatedShareBasedCompensationExpense_2_Q2_USD":6281555.0,"AllocatedShareBasedCompensationExpense_1_Q2_USD":4148025.0,"SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_0_Q2_shares":11295.0,"IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities_2_Q2_USD":-3857658.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_0_Q2_USD":259386596.0,"ProceedsFromStockOptionsExercised_2_Q2_USD":820165.0,"LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_0_Q2_USD":8000000.0,"LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_0_Q2_USD":8000000.0,"InterestExpenseDebtExcludingAmortization_1_Q2_USD":379167.0,"StockIssuedDuringPeriodSharesNewIssues_2_Q2_shares":141678.0,"ShareBasedCompensation_2_Q2_USD":6281555.0,"ResearchAndDevelopmentExpense_2_Q2_USD":38064357.0,"NetIncomeLoss_1_Q2_USD":-18326992.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-42168466.0,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":-10759.0,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":12895167.0,"LiabilitiesCurrent_0_Q2_USD":23001956.0,"LiabilitiesAndStockholdersEquity_0_Q2_USD":190989587.0,"Liabilities_0_Q2_USD":36746277.0,"IncreaseDecreaseInAccountsPayable_2_Q2_USD":-1580100.0,"GeneralAndAdministrativeExpense_2_Q2_USD":12205934.0,"NetIncomeLoss_2_Q2_USD":-50811138.0,"GeneralAndAdministrativeExpense_1_Q2_USD":7235877.0,"EarningsPerShareBasicAndDiluted_1_Q2_USD":-0.49,"Depreciation_2_Q2_USD":10960.0,"CommonStockValue_0_Q2_USD":3726.0,"CommonStockSharesOutstanding_0_Q2_shares":37267510.0,"CommonStockSharesIssued_0_Q2_shares":37267510.0,"AssetsCurrent_0_Q2_USD":190819290.0,"Assets_0_Q2_USD":190989587.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_2_Q2_shares":4166792.0,"AdditionalPaidInCapital_0_Q2_USD":380946215.0,"EarningsPerShareBasicAndDiluted_2_Q2_USD":-1.37,"PaymentsToAcquirePropertyPlantAndEquipment_2_Q2_USD":10759.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q2_USD":137181.0,"ProceedsFromIssuanceOfCommonStock_2_Q2_USD":12074999.0,"ResearchAndDevelopmentExpense_1_Q2_USD":10542957.0,"PreferredStockValue_0_Q2_USD":null,"PreferredStockSharesOutstanding_0_Q2_shares":0.0,"PreferredStockSharesIssued_0_Q2_shares":0.0,"PreferredStockSharesAuthorized_0_Q2_shares":10000000.0,"PreferredStockParOrStatedValuePerShare_0_Q2_USD":0.0001,"OperatingIncomeLoss_2_Q2_USD":-50270291.0,"OperatingIncomeLoss_1_Q2_USD":-17778834.0,"OperatingExpenses_2_Q2_USD":50270291.0,"OperatingExpenses_1_Q2_USD":17778834.0,"InterestPaidNet_2_Q2_USD":762501.0,"DebtInstrumentCarryingAmount_0_Q2_USD":20000000.0,"CommonStockSharesAuthorized_0_Q2_shares":150000000.0,"CommonStockParOrStatedValuePerShare_0_Q2_USD":0.0001,"AccountsPayableAndOtherAccruedLiabilitiesCurrent_0_Q2_USD":7091470.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_2_Q2_shares":37081064.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q2_shares":37100770.0,"StockholdersEquity_0_Q2_USD":154243310.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":-226706631.0,"PropertyPlantAndEquipmentNet_0_Q2_USD":30422.0,"ProfitLoss_2_Q2_USD":-50811138.0,"LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_0_Q2_USD":2666667.0,"NumberOfOperatingSegments_2_Q2_segment":1.0,"Ticker":"AXSM","CIK":"1579428","name":"AXSOME THERAPEUTICS, INC.","OfficialName":"Axsome Therapeutics Inc. Common Stock","form":"10-Q","period":"20200630","fy":"2020.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"1574461367.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20200810"}]